Full Panel Denies Rehearing in Fosamax Patent Case
home > blogdigger
Merck & Co. v. Teva Pharmaceuticals (Fed. Cir. 2005) (on petition for rehearing). Merck & Co. owns the patent on the best-selling drug Fosamax. Teva, a generic manufacturer lost an infringement case at the district court after the court found the patent valid and infringed. In January 2005, the Court of Appeals for the Federal Circuit reversed the district court — vacating the lower court’s finding of validity and infringement. Merck, with the amicus suppor ... (more)
- link to Full Panel Denies Rehearing in Fosamax Patent Case -
Last update: 05/26/2005